The 2020 ASTRO Annual Meeting will be held October 25-28 as an immersive and interactive virtual meeting

Contour Homework:
Primary GTV_BC on Slices 49, 50, 51, 52
CTV_HR_BC on Slices 49, 50, 51, 52
CTV_SR_BC on Slices 49, 50, 51, 52, 80

Disabled Contours: All
Enabled Reference Contours: None

Resource Files:
2020 eContouring for Head and Neck Cancer Squamous cell carcinoma of unknown primary of the head and neck (Tx N2 M0) Bhisham Chera
2020 eContouring for Head and Neck Cancer Unresectable Squamous Cell Carcinoma of the Maxillary Sinus (T4 N0 M0) Bhisham Chera
EduCase Contouring Homework Video Tutorial

Data and material from, or that you provide in connection with, this class may be used in an aggregate form without limitation by ASTRO or, as specified by ASTRO, by its designees/licensees. By providing such data or material, including drawings, and by participating in this class, you consent to this use.

The 2020 ASTRO Annual Meeting will be held October 25-28 as an immersive and interactive virtual meeting

Contour Homework:
GTV_Node_BC on Slices 78, 90
CTV_HR_BC on Slices 78, 90
CTV_IR_BC on Slices 55, 66, 78, 88
CTV_SR_BC on Slices 55, 66, 78, 90

Disabled Contours: All
Enabled Reference Contours: None

Resource Files:
2020 eContouring for Head and Neck Cancer Squamous cell carcinoma of unknown primary of the head and neck (Tx N2 M0) Bhisham Chera
2020 eContouring for Head and Neck Cancer Unresectable Squamous Cell Carcinoma of the Maxillary Sinus (T4 N0 M0) Bhisham Chera
EduCase Contouring Homework Video Tutorial

Data and material from, or that you provide in connection with, this class may be used in an aggregate form without limitation by ASTRO or, as specified by ASTRO, by its designees/licensees. By providing such data or material, including drawings, and by participating in this class, you consent to this use.

Sunday, September 24, 2017, 4:45 p.m. - 6:15 p.m. eContouring for Head and Neck Course II: Matthew Stenmark, MD, Sue Yom, MD, Suresh Mukherji, MD, MBA, FACR

Homework:
The GTVs have been defined for you based on physical examination and the pre-treatment imaging (CT, PET-CT, and MR).

Assuming a 35 fraction treatment regimen with concurrent platinum-based chemotherapy, please use the treatment planning CT to define:

Clinical target volumes, selecting from the following dose levels. You may use as many or as few as you see appropriate.
CTV_70 Gy (2.0 Gy/fx)
CTV_63 Gy (1.8 Gy/fx)
CTV_59.5 Gy (1.7 Gy/fx)
CTV_56 Gy (1.6 Gy/fx)

Organs at risk, including the pharyngeal constrictor muscles and the brachial plexus
Contour as many or as few as you see appropriate on slices: 76, 80, 84, 88, 92, 96, 100, 104, 108, 112, 116
(homework not engaged in UI)

Enabled Reference Contours: GTVs
Disabled Contours: All Except for GTVs

Resource Files:
T3N2c supraglottic sqcca Vignette
EduCase User Guide